Marvell bets $115 billion that AI scale runs on light, not just silicon
Marvell will acquire Lumentum in an all-stock transaction, combining chip and optical portfolios for AI infrastructure. The deal carries large termination fees, a long road to closing, and projections the companies themselves supply.
- Marvell will acquire Lumentum in an all-stock transaction with an implied enterprise value of $115 billion. Self-reported m:…1317
- Lumentum stockholders will receive 4.500 Marvell shares per Lumentum share, a premium of about 23.9% over unaffected closing prices as of October 28, 2026. Self-reported m:…1317
- The company says the combined company expects more than $1 billion in annual run-rate cost synergies and first-year accretion to non-GAAP earnings per share. Self-reported m:…1317
- Marvell would pay a $5.8 billion termination fee in specified circumstances, Lumentum would pay $2.9 billion, and a $3.2 billion regulatory termination fee applies if regulators block the deal. Self-reported m:…6407
- The transaction is expected to close in the first half of calendar 2028, subject to stockholder approval and regulatory clearance. Self-reported m:…1317 m:…6796
The deal on the table
Marvell Technology has signed a definitive agreement to acquire Lumentum in an all-stock transaction, according to filings both companies made with the Securities and Exchange Commission. The transaction carries an implied enterprise value of $115 billion for Lumentum, and Lumentum stockholders will receive a fixed exchange ratio of 4.500 Marvell shares for each Lumentum share they hold. m:…1317
The exchange ratio represents a premium of approximately 23.9% based on each company's unaffected closing share price as of October 28, 2026, the filings state. After closing, Marvell stockholders would own about 67% of the combined company and Lumentum stockholders about 33%. Matt Murphy will continue as chairman and chief executive of the combined company, and three Lumentum directors, including chief executive Michael Hurlston, will join the Marvell board. m:…1317
The agreement was entered into on November 1, 2026, according to the merger agreement filings, and the Marvell board has unanimously approved it and recommended stockholder approval. Lumentum equity awards will convert into equivalent Marvell equity awards, with performance stock units converting to time-vesting restricted stock units. m:…6407
Why photonics, and why now
The filings give the deal's shape: Marvell will acquire Lumentum in an all-stock transaction, with Lumentum stockholders receiving a fixed exchange ratio of 4.500 Marvell shares for each Lumentum share, the filing says. The transaction carries an implied enterprise value of $115 billion, and Marvell stockholders will own approximately 67% of the combined company, with Lumentum stockholders owning approximately 33%. m:…1317
The companies also set out the expected economics in the filing: the combined company expects more than $1 billion in annual run-rate cost synergies, and the transaction is expected to be accretive to Marvell non-GAAP earnings per share in the first year after close, the company says. Three Lumentum directors, including chief executive Michael Hurlston, will join Marvell's board, and Matt Murphy will continue as chairman and chief executive of the combined company. m:…1317
The company says the combined company expects to achieve more than $1 billion in annual run-rate cost synergies, and that the transaction is expected to add to Marvell's non-GAAP earnings per share in the first year after closing. Both are company projections, not results, and they depend on an integration that has not yet happened. m:…1317
What could still stop it
The price of failure is written into the agreement in unusual detail. Marvell would pay Lumentum a $5.8 billion termination fee under specified circumstances, Lumentum would pay Marvell $2.9 billion under specified circumstances, and a separate $3.2 billion regulatory termination fee applies if the merger is blocked by antitrust or regulatory authorities, according to the filings. m:…6407
The merger is subject to customary closing conditions, including stockholder approval and regulatory clearance under the Hart-Scott-Rodino Act, Lumentum's filing states. The agreement sets an initial outside date of November 1, 2027, with potential extensions to August 1, 2028, which means the timeline could stretch well beyond a year even before the expected closing window. m:…6796
The expected closing in the first half of calendar 2028 sits beyond that initial outside date, so the extension mechanics and the regulatory process are not footnotes here. They are the path the deal has to survive, and the termination fees show both sides priced that risk in billions. m:…1317 m:…6407
What to watch
Three things will tell whether this bet pays off. First, whether regulators clear a combination of this size in chips and optics without conditions that blunt the integration. Second, whether the companies file the joint registration statement on Form S-4 with the SEC and win stockholder approval on schedule. Third, whether the promised synergies show up in reported results after closing, rather than remaining a filing-day projection. m:…6407 m:…1317
For executives building AI infrastructure, the immediate takeaway is narrower: the deal's closing conditions matter as much as its size. The merger is subject to stockholder approval and regulatory clearance, the filing says, with an initial outside date of November 1, 2027, extendable to August 1, 2028, and termination fees on both sides if it fails, including a $3.2 billion regulatory termination fee. m:…1317
What is still unresolved
- Whether regulators will clear the deal, and on what conditions.
- Whether the projected $1 billion-plus in annual cost synergies will materialize after closing.
- How the combined product portfolio will actually be integrated across chip and optical lines.
Provenance by Synorb. Every claim links to its source. This story was written by an agent from the Manifests listed below. Read the methodology and limitations, or send a correction.
Free to reuse, including commercially. Credit “Hanging Context, with provenance by Synorb” and link to this story. Keep the cited Manifest ids. Reuse terms v1.